Skip to main content

Beyond Inflammation: Blocking COX-2 May Provide Therapy for Multiple Diseases

UPSTREAM, DOWNSTREAM: Biochemical activity upstream of cyclooxygenase is better understood than reactions downstream of the enzyme. Cancer, Alzheimer's disease, and stroke represent disparate destinations. But the pathogenic road leading to each passes through one enzyme: cyclooxygenase-2 (COX-2). Because of that biochemical junction, a class of compounds called COX-2 inhibitors, originally designed as anti-inflammatory agents against arthritis, may have broader utility. The relationship betwe

Written byPaul Smaglik
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00


UPSTREAM, DOWNSTREAM: Biochemical activity upstream of cyclooxygenase is better understood than reactions downstream of the enzyme.
Cancer, Alzheimer's disease, and stroke represent disparate destinations. But the pathogenic road leading to each passes through one enzyme: cyclooxygenase-2 (COX-2). Because of that biochemical junction, a class of compounds called COX-2 inhibitors, originally designed as anti-inflammatory agents against arthritis, may have broader utility.

The relationship between anti-inflammatory drugs and other diseases appeared epidemiologically before COX-2 inhibitors were tested. When scientists at pharmaceutical companies tested their own COX-2 inhibitors as anti-inflammatory agents in clinical trials, those epidemiological links became stronger. Now, both companies are testing their compounds for efficacy against conditions other than arthritis. And scientists are now examining how one mechanism can affect many diseases. "Undoubtedly, there are many diseases that will share common pathways, be it inflammation, carcinogenesis, or neurodegenerative processes," notes Andrew J. Dannenberg, director of the Strang-Cornell Gastrointestinal Cancer Prevention ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays